DTC Marketing
Swoop
From Signals to Outcomes: 5 Healthcare Trends Shaping the Information Age
Industry leaders at SXSW 2026 explored how AI, data, and evolving patient behaviors redefine the pharma marketing landscape.
Marcella Milliet Sciorra
The Future of Rare Disease Marketing is Patient-First and Privacy-Safe
Swoop helps brands find, engage, and support rare disease patients earlier through privacy-safe, data-driven solutions.
Communities | Product Overviews
Swoop
Smarter Intelligence, Deeper Connection: Redefining Brand Marketing in 2026
Swoop's 2026 innovations build a truly patient-first marketing strategy.
Eric Peacock
Why AI is Fueling the Growth of Patient Communities
Google’s shift toward AI-generated answers removes blue search links often without clear attribution or context.
Swoop
Beyond the Buzz: A Practical Framework for AI-Powered Pharma Marketing
Translate buzzwords into brand strategies that impact patient lives with this webinar featuring Romain Bogaerts.
Swoop
Beyond the Buzz: A Practical Framework for AI-Powered Pharma Marketing
Translate buzzwords into brand strategies that impact patient lives with this webinar featuring Romain Bogaerts.
Swoop
83% of Chronic Condition Patients Surveyed Find Pharma Ads Beneficial
Patient Perspectives on Pharmaceutical Advertising: Exclusive Insights from Swoop
DTC Marketing | White Papers
Swoop
DSP Diagnosis: 10 Factors Pharma Marketers Should Consider
In today’s complex healthcare marketing landscape, selecting the right Demand-Side Platform (DSP) is crucial for pharmaceutical brands aiming to deliver impactful, targeted, and compliant omnichannel campaigns to patients and healthcare providers (HCPs). This checklist will guide you through the essential factors to consider, ensuring that your chosen DSP aligns with your marketing objectives, respects patient […]
DTC Audiences | Product Overviews
Swoop
Swoop DTC Audiences Overview
Reach 99% of your DTC target with Swoop’s 100% compliant audiences across all 50 states.
Eric Peacock
The Rare Disease Marketing Guide: 5 Strategies Every Pharma Marketer Needs To Know for Patient Engagement
R&D in rare diseases has skyrocketed. Thirty percent of today’s R&D pipeline is in rare diseases, and 40 percent of overall pipeline growth since 2013 is due to rare diseases.